🟢 CalciMedica is trading 9.8% up in after-hours trading with no clear catalyst identified

CalciMedica is trading at $1.80, up 9.76%, in after-hours trading with no verified October 1 announcement or clear catalyst identified.

• A September 30 prospectus supplement disclosed potential sales of up to $25 million in common stock through an existing at-the-market offering; it does not establish a reason for the rise.
• CalciMedica’s filings page lists a September 30 Form 8-K, but the available listing does not identify its subject. Broader market context was mixed, so the move cannot be confidently attributed to overall market sentiment.